Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea
- PMID: 30416412
- PMCID: PMC6221859
- DOI: 10.3346/jkms.2018.33.e304
Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea
Abstract
Background: The Republic of Korea has a very low prevalence of human immunodeficiency virus (HIV) infection, but the number of new HIV diagnoses has steadily risen, strongly indicating a large number of undetected HIV infections. Thus, it is important for Korean public health authorities to adopt and encourage cost-effective HIV detection tools, such as rapid HIV screening tests. In this study, we aimed to evaluate the cost-effectiveness of enzyme-linked immunosorbent assays (ELISA) and rapid tests in a public health center (PHC) setting.
Methods: We developed a decision analytic model to assess the per-examinee cost and the cost-effectiveness of identifying HIV patients in a PHC setting using two HIV testing strategies: conventional HIV screening by ELISA versus rapid HIV testing. Analysis was performed in two scenarios: HIV testing in an average-risk population and in a high-risk population.
Results: Compared to the ELISA, the rapid test was cost-saving and cost-effective. The per-examinee cost was USD 1.61 with rapid testing versus USD 3.38 with ELISA in an average-risk population, and USD 4.77 with rapid testing versus USD 7.62 with ELISA in a high-risk population. The cost of identifying a previously undiagnosed HIV case was USD 26,974 with rapid testing versus USD 42,237 with ELISA in an average-risk population, and USD 153 with rapid testing versus USD 183 with ELISA in a high-risk population.
Conclusion: Rapid testing would be more cost-effective than using conventional ELISA testing for identifying previously undiagnosed HIV-infected cases in Korea, a country with extremely low HIV prevalence.
Keywords: Cost-effectiveness Analysis; HIV Screening Test; Korea.
Conflict of interest statement
Disclosure: The authors have no potential conflicts of interest to disclose.
Figures
Similar articles
-
Reducing the cost of HIV antibody testing.Lancet. 1993 Jul 10;342(8863):87-90. doi: 10.1016/0140-6736(93)91289-x. Lancet. 1993. PMID: 8100916
-
Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.Pediatrics. 2000 Apr;105(4):E54. doi: 10.1542/peds.105.4.e54. Pediatrics. 2000. PMID: 10742375
-
Three-year outcome of rapid HIV testing at public health centers in Seoul, Republic of Korea: a short report.AIDS Care. 2021 Apr;33(4):525-529. doi: 10.1080/09540121.2020.1749550. Epub 2020 Apr 11. AIDS Care. 2021. PMID: 32279532
-
Benefits of HIV screening of blood transfusions in Zambia.Lancet. 1995 Jul 22;346(8969):225-7. doi: 10.1016/s0140-6736(95)91272-x. Lancet. 1995. PMID: 7616804
-
Cost-effectiveness of HIV testing and treatment in the United States.Clin Infect Dis. 2007 Dec 15;45 Suppl 4(Suppl 4):S248-54. doi: 10.1086/522546. Clin Infect Dis. 2007. PMID: 18190295 Free PMC article. Review.
Cited by
-
Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea.BMC Pulm Med. 2020 Dec 2;20(1):316. doi: 10.1186/s12890-020-01351-z. BMC Pulm Med. 2020. PMID: 33267859 Free PMC article.
-
Prediction of treatment failure and compliance in patients with tuberculosis.BMC Infect Dis. 2020 Aug 24;20(1):622. doi: 10.1186/s12879-020-05350-7. BMC Infect Dis. 2020. PMID: 32831044 Free PMC article.
-
COPD Risk Factor Profiles in General Population and Referred Patients: Potential Etiotypes.Int J Chron Obstruct Pulmon Dis. 2023 Nov 9;18:2509-2520. doi: 10.2147/COPD.S427774. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37965078 Free PMC article.
-
Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study.BMC Infect Dis. 2019 Aug 22;19(1):735. doi: 10.1186/s12879-019-4365-9. BMC Infect Dis. 2019. PMID: 31438876 Free PMC article.
-
Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study.Sci Rep. 2020 Sep 3;10(1):14609. doi: 10.1038/s41598-020-71565-y. Sci Rep. 2020. PMID: 32884082 Free PMC article.
References
-
- Korea Centers for Diseases Control and Prevention. The Status of HIV/AIDS Infection of Korea. Cheongju: Korea Centers for Disease Control and Prevention; 2016.
-
- Joint United Nations Programme on HIV/AIDS. Global AIDS Update 2016. Geneva: UNAIDS; 2016.
-
- Choi JH, Kim S, Park P, Cho KS. HIV/AIDS Notifications in Korea, 2016. Cheongju: Korea Centers for Disease Control and Prevention; 2017.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical